Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis.

about

Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q55491477

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Association between plasminoge ...... atic review and meta-analysis.

@en

Association between plasminoge ...... atic review and meta-analysis.

@nl

type

Item

label

Association between plasminoge ...... atic review and meta-analysis.

@en

Association between plasminoge ...... atic review and meta-analysis.

@nl

prefLabel

Association between plasminoge ...... atic review and meta-analysis.

@en

Association between plasminoge ...... atic review and meta-analysis.

@nl

P1476

Association between plasminoge ...... matic review and meta-analysis

@en

P2093

Alisha Labinaz

http://www.w3.org/2001/XMLSchema#string

F Daniel Ramirez

http://www.w3.org/2001/XMLSchema#string

Mohammad Ali Faraz

http://www.w3.org/2001/XMLSchema#string

Pietro Di Santo

http://www.w3.org/2001/XMLSchema#string

Pouya Motazedian

http://www.w3.org/2001/XMLSchema#string

Richard G Jung

http://www.w3.org/2001/XMLSchema#string

Trevor Simard

http://www.w3.org/2001/XMLSchema#string

Young Jung

http://www.w3.org/2001/XMLSchema#string

P2860

The case of the misleading funnel plot

Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population

Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication

Platelets retain high levels of active plasminogen activator inhibitor 1

Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?

Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.

Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis.

von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.

PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting

Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12959-018-0166-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sarah Visintini

Benjamin Hibbert

P577

2018-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29991926

http://www.w3.org/2001/XMLSchema#string

P932

5987541

http://www.w3.org/2001/XMLSchema#string